Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines (original) (raw)

• Banchereau, J. & Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25, 383–392 (2006).
  Article CAS Google Scholar
• Luo, J.L., Maeda, S., Hsu, L.C., Yagita, H. & Karin, M. Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 6, 297–305 (2004).
  Article CAS Google Scholar
• Lin, W.W. & Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175–1183 (2007).
  Article CAS Google Scholar
• Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499–511 (2004).
  Article CAS Google Scholar
• Karin, M., Lawrence, T. & Nizet, V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124, 823–835 (2006).
  Article CAS Google Scholar
• Pasare, C. & Medzhitov, R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560, 11–18 (2005).
  Article CAS Google Scholar
• Vogel, S.N., Fitzgerald, K.A. & Fenton, M.J. TLRs: differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3, 466–477 (2003).
  Article CAS Google Scholar
• Doyle, S. et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17, 251–263 (2002).
  Article CAS Google Scholar
• Medzhitov, R. et al. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2, 253–258 (1998).
  Article CAS Google Scholar
• Yamamoto, M. et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169, 6668–6672 (2002).
  Article CAS Google Scholar
• Hoebe, K. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424, 743–748 (2003).
  Article CAS Google Scholar
• Bin, L.H., Xu, L.G. & Shu, H.B. TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling. J. Biol. Chem. 278, 24526–24532 (2003).
  Article CAS Google Scholar
• Yamamoto, M. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4, 1144–1150 (2003).
  Article CAS Google Scholar
• Fitzgerald, K.A. et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413, 78–83 (2001).
  Article CAS Google Scholar
• Horng, T., Barton, G.M. & Medzhitov, R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2, 835–841 (2001).
  Article CAS Google Scholar
• Kawai, T. & Akira, S. TLR signaling. Semin. Immunol. 19, 24–32 (2007).
  Article CAS Google Scholar
• Hacker, H. et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204–207 (2006).
  Article Google Scholar
• Oganesyan, G. et al. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208–211 (2006).
  Article CAS Google Scholar
• Matsuzawa, A. et al. Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex. Science 321, 663–668 (2008).
  Article CAS Google Scholar
• Inoue, J., Gohda, J. & Akiyama, T. Characteristics and biological functions of TRAF6. Adv. Exp. Med. Biol. 597, 72–79 (2007).
  Article Google Scholar
• Petersen, S.L. et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12, 445–456 (2007).
  Article CAS Google Scholar
• Li, L. et al. A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death. Science 305, 1471–1474 (2004).
  Article CAS Google Scholar
• Vallabhapurapu, S. et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9, 1364–1370 (2008).
  Article CAS Google Scholar
• Werneburg, B.G., Zoog, S.J., Dang, T.T., Kehry, M.R. & Crute, J.J. Molecular characterization of CD40 signaling intermediates. J. Biol. Chem. 276, 43334–43342 (2001).
  Article CAS Google Scholar
• Kagan, J.C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-β. Nat. Immunol. 9, 361–368 (2008).
  Article CAS Google Scholar
• Núñez Miguel, R. et al. A dimer of the Toll-like receptor 4 cytoplasmic domain provides a specific scaffold for the recruitment of signalling adaptor proteins. PLoS One 2, e788 (2007).
  Article Google Scholar
• Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839–850 (2006).
  Article CAS Google Scholar
• Lamothe, B. et al. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IκB kinase activation. J. Biol. Chem. 282, 4102–4112 (2007).
  Article CAS Google Scholar
• Vaux, D.L. & Silke, J. IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6, 287–297 (2005).
  Article CAS Google Scholar
• Li, X., Yang, Y. & Ashwell, J.D. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 416, 345–347 (2002).
  Article Google Scholar
• Uematsu, S. & Akira, S. Toll-like receptors and type I interferons. J. Biol. Chem. 282, 15319–15323 (2007).
  Article CAS Google Scholar
• O'Neill, L.A. & Bowie, A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353–364 (2007).
  Article CAS Google Scholar
• Pineda, G., Ea, C.K. & Chen, Z.J. Ubiquitination and TRAF signaling. Adv. Exp. Med. Biol. 597, 80–92 (2007).
  Article Google Scholar
• Yamamoto, M. et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7, 962–970 (2006).
  Article CAS Google Scholar
• Sato, S. et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6, 1087–1095 (2005).
  Article CAS Google Scholar
• Kawai, T., Adachi, O., Ogawa, T., Takeda, K. & Akira, S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11, 115–122 (1999).
  Article CAS Google Scholar
• Keats, J.J. et al. Promiscuous mutations activate the noncanonical NF-κB pathway in multiple myeloma. Cancer Cell 12, 131–144 (2007).
  Article CAS Google Scholar
• Park, J.M. et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis–CREB and NF-κB as key regulators. Immunity 23, 319–329 (2005).
  Article CAS Google Scholar
• Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003).
  Article CAS Google Scholar
• Lawrence, T., Bebien, M., Liu, G.Y., Nizet, V. & Karin, M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138–1143 (2005).
  Article CAS Google Scholar
• Beaumelle, B.D., Gibson, A. & Hopkins, C.R. Isolation and preliminary characterization of the major membrane boundaries of the endocytic pathway in lymphocytes. J. Cell Biol. 111, 1811–1823 (1990).
  Article CAS Google Scholar
• Johnson, G.L. & Bourne, H.R. Influence of cholera toxin on the regulation of adenylate cyclase by GTP. Biochem. Biophys. Res. Commun. 78, 792–798 (1977).
  Article CAS Google Scholar
• Iwamura, T. et al. Induction of IRF-3/-7 kinase and NF-κB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6, 375–388 (2001).
  Article CAS Google Scholar